跳至主要内容
临床试验/CTRI/2019/04/018393
CTRI/2019/04/018393招募中3 期

Efficacy of Prophylactic administration of BifidoBacterBreve M16 V on decreasing Late onset sepsis among Preterm Neonates 28-32 weeks or Very Low birth weight babies: A Before and after study

ational Health Mission0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Preterm babies gestational age between 28 weeks and 31 6/7 weeks or less than 1500 grams
  • Age less than 72 hours

排除标准

  • Lethal congenital malformation known at trial entry
  • Any known Major gastrointestinal malformation or Medical indication preventing initiation of enteral feed within 72 hours of life.
  • Babies requiring More than two inotropic support
  • Babies with positive CRP or growth in blood culture within 72 hours of life

研究者

发起方
ational Health Mission

相似试验